ACQUIRED RESISTANCE TO PD-(L)1 BLOCKADE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0

作者：

Ricciuti, Biagio ^{[1
]}

Lamberti, Giuseppe ^{[1
]}

Alessi, Joao Victor ^{[1
]}

Pecci, Federica ^{[1
]}

Di Federico, Alessandro ^{[1
]}

Wang, Xinan ^{[2
]}

Barrichello, Adriana ^{[1
]}

Vaz, Victor ^{[1
]}

Pangilinan, Andy ^{[1
]}

Haradon, Danielle ^{[1
]}

Elinton, Lee ^{[1
]}

Nishino, Mizuki ^{[3
]}

Rodig, Scott ^{[3
]}

Sholl, Lynette ^{[3
]}

Awad, Mark ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Harvard TH Chan Sch Publ Hlth, Boston, MA USA

[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.0528

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

528

引用

页码：A553 / A554

页数：2

共 50 条

[1] Genomic correlates of acquired resistance to PD-(L)1 blockade in patients with advanced non-small cell lung cancer (NSCLC).
Ricciuti, Biagio
Alessi, Joao Victor Machado
Li, Yvonne Y.
Vaz, Victor R.
Pecci, Federica
Lamberti, Giuseppe
de Castro Barrichello, Adriana Paula
Gupta, Hersh
Nishino, Mizuki
Cherniack, Andrew D.
Sholl, Lynette M.
Rodig, Scott J.
Awad, Mark M.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[2] Genomic and immunophenotypic landscape of acquired resistance to PD-(L)1 blockade in non-small cell lung cancer
Ricciuti, Biagio
Lamberti, Giuseppe
Puchala, Sreekar
Mahadevan, Navin
Alessi, Joao
Wang, Xinan
Li, Yvonne
Pecci, Federica
Di Federico, Alessandro
Gandhi, Malini
Barrichello, Adriana
Vaz, Victor
Pangilinan, Andy
Haradon, Danielle
Lee, Elinton
Gupta, Hersh
Nishino, Mizuki
Cherniack, Andrew
Rodig, Scott
Sholl, Lynette
Umeton, Renato
Awad, Mark M.
CANCER RESEARCH, 2023, 83 (07)
[3] Impact of age on outcomes with PD-(L)1 blockade in patients (Pts) with non-small cell lung cancer (NSCLC).
Lichtenstein, Morgan
Nipp, Ryan David
Goodwin, Kelly
Anderson, Danyon
Newcomb, Richard
Gainor, Justin F.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
Ricciuti, Biagio
Lamberti, Giuseppe
Puchala, Sreekar R.
Mahadevan, Navin R.
Lin, Jia-Ren
Alessi, Joao V.
Chowdhury, Alexander
Li, Yvonne Y.
Wang, Xinan
Spurr, Liam
Pecci, Federica
Di Federico, Alessandro
Venkatraman, Deepti
Barrichello, Adriana P.
Gandhi, Malini
Vaz, Victor R.
Pangilinan, Andy J.
Haradon, Danielle
Lee, Elinton
Gupta, Hersh
Pfaff, Kathleen L.
Welsh, Emma L.
Nishino, Mizuki
Cherniack, Andrew D.
Johnson, Bruce E.
Weirather, Jason L.
Dryg, Ian D.
Rodig, Scott J.
Sholl, Lynette M.
Sorger, Peter
Santagata, Sandro
Umeton, Renato
Awad, Mark M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (11) : 1311 - 1321
[5] Immunosenescence Correlates with Poor Outcome from PD-(L)1 Blockade but Not Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
Ferrara, R.
Naigeon, M.
Auclin, E.
Duchemann, B.
Cassard, L.
Medhi, J. J.
Boselli, L.
Grivel, J.
Desnoyer, A.
Texier, M.
Mezquita, L.
Aboubakar, F.
Hendriks, L.
Planchard, D.
Caramella, C.
Remon, J.
Ngocamus, M.
Nicotra, C.
Proto, C.
Sangaletti, S.
Chaput, N.
Besse, B.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S452 - S452
[6] Clinical Characteristics of Acquired Resistance with Anti-PD-1/PD-L1 in Non-Small Cell Lung Cancer (NSCLC)
Shah, Shalin
Wood, Kevin
Brisson, Ryan
Karrison, Theodore
Hensing, Thomas
Luke, Jason J.
Patel, Jyoti D.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S310 - S310
[7] Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer
Arbour, K.
Oprescu, M.
Hakim, J.
Rizvi, H.
Leiserson, M.
Ginsburg, M.
Plodkowski, A.
Sauter, J.
Preeshagul, I.
Gillett, S.
Rosenfield, P.
Mackey, L.
Dudik, M.
Hellmann, M.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S290 - S290
[8] Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer
Vanguri, Rami S.
Luo, Jia
Aukerman, Andrew T.
Egger, Jacklynn, V
Fong, Christopher J.
Horvat, Natally
Pagano, Andrew
Araujo-Filho, Jose De Arimateia Batista
Geneslaw, Luke
Rizvi, Hira
Sosa, Ramon
Boehm, Kevin M.
Yang, Soo-Ryum
Bodd, Francis M.
Ventura, Katia
Hollmann, Travis J.
Ginsberg, Michelle S.
Gao, Jianjiong
Hellmann, Matthew D.
Sauter, Jennifer L.
Shah, Sohrab P.
NATURE CANCER, 2022, 3 (10) : 1151 - +
[9] Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer
Rami S. Vanguri
Jia Luo
Andrew T. Aukerman
Jacklynn V. Egger
Christopher J. Fong
Natally Horvat
Andrew Pagano
Jose de Arimateia Batista Araujo-Filho
Luke Geneslaw
Hira Rizvi
Ramon Sosa
Kevin M. Boehm
Soo-Ryum Yang
Francis M. Bodd
Katia Ventura
Travis J. Hollmann
Michelle S. Ginsberg
Jianjiong Gao
Matthew D. Hellmann
Jennifer L. Sauter
Sohrab P. Shah
Nature Cancer, 2022, 3 : 1151 - 1164
[10] TUMORAL AND PERIPHERAL IMMUNOPHENOTYPE OF REFRACTORY VS RELAPSE TO PD-(L)1 BLOCKADE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
Ascierto, Maria
Hellmann, Matthew
Standifer, Nathan
Wu, Song
Si, Han
Morehouse, Chris
Rebelatto, Marlon
Abdullah, Shaad
Raja, Rajiv
Soria, Jean-Charles
Germa, Caroline
Barrett, Carl
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A167 - A167

← 1 2 3 4 5 →